With initiatives focused in basic and clinical research, the Stem Cell Center seeks to leverage the regenerative properties of stem cells to help patients suffering from cardiovascular disease by improving treatment options and even reversing the effects of disease or damage to the heart. The team also utilizes their discoveries to further stem cell therapies across all areas of medicine.
The department has various ongoing research projects and clinical trials that are designed to uncover groundbreaking insights that will bridge the basic science understanding of stem cell action with bedside treatment strategies for patients. Through the department’s prestigious partnership with the Cardiovascular Cell Therapy Research Network (CCTRN) and industry sponsors, several clinical trials are currently underway. These clinical studies leverage previous discoveries and findings made by the department and represent a promising path to the first approved cell therapy to treat heart failure.
In addition to the team’s cutting-edge translational research, they are also pioneers in the use of NOGA mapping technology to improve targeting strategies for cell delivery. The team continues to hone their skills in this area, establishing best practices for other clinicians to utilize as the field of stem cell therapy advances and treatments are made available.
In the spirit of sharing learnings to advance the field, the SCC hosted THI’s first International Symposium on Cardiovascular Regenerative Medicine in 2107. Experts from around the world came together to discuss and debate the state of the field in order to build the framework for the clinical implementation of regenerative medicine and to further develop our understanding of stem cell therapies to treat cardiovascular disease.
The THI Stem Cell Center is screening for eligible patients with heart failure to participate in clinical trials using adult stem cells. Learn more.
If you would like to be screened for one of our clinical trials, complete this Patient Information Form